Trails Edge Capital Partners’s ImageneBio IMA Stock Holding History
Bought
Maintained
Sold
Other funds holding IMA
BCM
Trails Edge Capital Partners's IMA Position: Q3 2026 in Review
Trails Edge Capital Partners increased its ImageneBio (IMA) stake by 288% in Q3 2026, buying an estimated $4.41M and bringing the position to 1,094,045 shares worth $5.01M. The position accounts for 0.72% of the portfolio, ranked #34.
Trails Edge Capital Partners first reported a position in IMA in Q2 2026 and has held it in 2 quarters since. 37 funds tracked by Wall St. Rank hold IMA as of Q3 2026.
- Trails Edge Capital Partners held 1,094,045 shares of ImageneBio worth $5.01M as of Q3 2026.
- Trails Edge Capital Partners bought 812,041 ImageneBio shares in Q3 2026, an estimated $4.41M.
- ImageneBio made up 0.72% of Trails Edge Capital Partners's portfolio in Q3 2026, its #34 holding.
- Trails Edge Capital Partners first reported a position in ImageneBio in Q2 2026 and has held it in 2 quarters since.
- 37 funds tracked by Wall St. Rank held ImageneBio as of Q3 2026.
Based on Trails Edge Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.